Q3 2025 13F Holders as of 9/30/2025
-
Type / Class
-
Equity / COMMON STOCK
-
Shares outstanding
-
71.8M
-
Number of holders
-
205
-
Total 13F shares, excl. options
-
80.9M
-
Shares change
-
+2.04M
-
Total reported value, excl. options
-
$4.58B
-
Value change
-
+$140M
-
Put/Call ratio
-
0.4
-
Number of buys
-
115
-
Number of sells
-
-90
-
Price
-
$56.60
Significant Holders of Kymera Therapeutics, Inc. - COMMON STOCK (KYMR) as of Q3 2025
250 filings reported holding KYMR - Kymera Therapeutics, Inc. - COMMON STOCK as of Q3 2025.
Kymera Therapeutics, Inc. - COMMON STOCK (KYMR) has 205 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 80.9M shares
.
Largest 10 shareholders include BAKER BROS. ADVISORS LP (6.65M shares), Avoro Capital Advisors LLC (6.35M shares), FMR LLC (5.88M shares), BVF INC/IL (5.5M shares), VANGUARD GROUP INC (5.42M shares), WELLINGTON MANAGEMENT GROUP LLP (5.2M shares), PRICE T ROWE ASSOCIATES INC /MD/ (5.1M shares), Atlas Venture Life Science Advisors, LLC (4.9M shares), BlackRock, Inc. (4.37M shares), and Siren, L.L.C. (3.43M shares).
This table shows the top 205 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.